Introduction For many years now, investing in healthcare related stocks has presented me with a conundrum of sorts. Demographic forces, primarily the graying of America (and the world for that matter), suggests powerful future growth potential and demand for healthcare related products and services. On the other hand, healthcare and its costs have long been …
Research Articles
Cardinal Health: A Dividend Aristocrat the Risk Is Already Priced In-Part 2 of 7
Introduction As a value investor, I am totally cognizant of the reality that attractively valued bargains are hard to find in a strong bull market. Moreover, as an experienced value investor I clearly understand that low valuations in a raging bull market are usually associated with issues and challenges sometimes real, sometimes imaginary. The key …
Aflac: A Valuation Conundrum? Fairly Valued Dividend Aristocrats: Part 1 of 7
Introduction Aflac (AFL) is a Dividend Aristocrat that has increased its dividend for 35 consecutive years. However, it is only one of seven Dividend Aristocrats that I consider attractively valued in light of the current bull market. Therefore, this will be the first in a series of seven articles where I will cover these seven …
Are These 5 Dow Stocks As Cheap As They Appear?: Part 5 of 5
Introduction This is the final installment of the five-part series where I examined the past operating histories and valuations of the 30 Dow Jones Industrial Average stocks. With this 5 Part series I attempted to cover the 30 Dow stocks in order of highest valuations to lowest. For the most part, I suggested that the …
Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
Introduction Thus far, with the first 3 parts of this five-part series, we’ve examined 60% (18 of 30) of the 30 stocks in the Dow Jones Industrial Average. What we found so far were that the majority of these constituents are currently overvalued or at least fully valued. Finally, with this Part 4, we will …
Are These The 6 Best Stocks In The Dow Jones Industrial Average? – Part 3 Of 5
Introduction In Part 1 and Part 2 of this series I covered 12 of the 30 Dow Jones Industrial Average stocks that I considered the most expensive of the index. With this part 3 I will be looking at 6 additional Dow stocks that for the most part I would consider fully valued to only …
The 6 Most Expensive Stocks in the Dow Jones Industrial Average: Part 1 of 5
Introduction When the Dow Jones Industrial Average first hit 20,000 in January of this year it generated quite a buzz within the financial community. Since January the Dow Jones Index has continued to rise and currently is over 22,700. However, the Dow Jones is not the only market index that is currently sitting at or …
What Could I Realistically Make If I Invested in Apple Today?
Introduction Just as it always does, Apple’s (AAPL) Keynote event generated quite a buzz. In addition to announcing several new products and upgrades, this year’s event inaugurated the Steve Jobs Theater at Apple Park. And as usual, reactions to the presentation have been quite strong. Perhaps more than any other company, Apple has both zealous …
My Visa Long is Getting Long in the Tooth
Introduction Over my lifetime I have invested in many different things. In the process of doing that, I have learned that there are really only two types of investors. As an investor, you are either active or passive. Being active implies directly managing or being in control of your investment. In contrast, as a passive …
Choosy Investors Choose J.M. Smucker and The Dividend Adds Value
Introduction The J.M. Smucker Company (SJM) is a “Dividend Contender” that has increased its dividend for 20 consecutive years. After being overvalued for most of fiscal year 2017 (fiscal year ends in April) the company has since fallen into attractive valuation territory. As a result, the company is available at a low P/E ratio relative …